Age dependence of clinical and pathological manifestations of autoimmune demyelination: Implications for multiple sclerosis

American Journal of Pathology

Volumn 155, Issue 4, 1999, Pages 1147-1161

  Smith, Mary E ^a,b   Eller, Nancy L ^a,c   McFarland, Henry F ^a   Racke, Michael K ^a,d   Raine, Cedric S ^e  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN BASIC PROTEIN;

ADOLESCENT; ADOPTIVE TRANSFER; AGE; ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATION; FEMALE; HISTOPATHOLOGY; MALE; MOUSE; MULTIPLE SCLEROSIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RELAPSE; REMISSION; SENSITIZATION;

EID: 0032849915     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65218-2     Document Type: Article

References (71)

1. Whitaker JN, Mitchell G: Clinical features of multiple sclerosis. Multiple Sclerosis: Clinical and Pathogenetic Basis. Edited by CS Raine, HF McFarland, WW Tourtellotte. London, Chapman and Hall, 1997, pp 3-20
2. Raine CS: The neuropathotogy of multiple sclerosis. Multiple Sclerosis: Clinical and Pathogenetic Basis. Edited by CS Raine, HF McFarland, WW Tourtellotte. London, Chapman and Hall, 1997, pp 151-171
3. Kurtzke J.F: Epidemiological evidence for MS as an infection. Clin Microbiol Rev 1993, 6:382-427
4. Poskanzer D, Schapira K, Miller H: MS and poliomyelitis. Lancet 1963, 11:917-921
5. Kurtzke J, Hyllested K: Multiple sclerosis in the Faroe Islands. I. Clinical and epidemiological features. Ann Neurol 1979, 5:6-21
6. Norman J, Kurtzke J, Beebe G: Epidemiology of multiple sclerosis in U.S. veterans: 2. Latitude, climate and the risk of multiple sclerosis. J Chron Dis 1983, 36:551-559
7. Xu XX, McFarlin DE: Oligoclonal bands in CSF of twins with multiple sclerosis. Neurology 1984, 34:769-774
8. McFarland HF, Patronas NJ, McFarlin DE, Mandler RN, Beall SS, Cross AH, Goodman A, Krebs H: Studies of multiple sclerosis in twins using MRI (abstract). Neurology 1985, 35:137
9. Kurtzke J, and Hyllested K: Multiple sclerosis in the Faroe Islands. II. Clinical update, transmission, and the nature of multiple sclerosis. Neurology 1986, 36:307-328
10. Uitdehaag BM, Polman CH, Valk J, Koetsier JC, Lucas CJ: Magnetic resonance imaging studies in multiple sclerosis twins. J Neurol Neurosurg Psychiat 1989, 52:1417-1419
11. Mumford CJ, Wood NW, Kellar-Wood H, Thorpe JW, Miller DH, Compston DA: The British Isles survey of multiple sclerosis in twins Neurology 1994, 44:11-15
12. Thorpe JW, Mumford CJ, Compston DA, Kendall BE, MacManus DG, McDonald WI, Miller DH: British Isles survey of MS in twins: MRI. J Neurol Neurosurg Psychiat 1994, 57:491-496
13. Ferraro A, Cazzullo CL: Chronic experimental allergic encephalomyelitis in monkeys. J Neuropathol Exp Neurol 1948, 7:235-245
14. McFarlin DE, Blank SE, Kibler RF: Recurrent experimental allergic encephalomyelitis in the Lewis rat. J Immunol 1974, 113:712-715
15. Stone SH, Lerner EM: Chronic disseminated allergic encephalomyelitis in guinea pigs. Ann NY Acad Sci 1965, 122:227-241
16. Raine CS, Snyder DH, Valsamis MP, Stone SH: Chronic experimental allergic encephalomyelitis in inbred guinea pigs: an ultrastructural study. Lab Invest 1974, 31:369-380
17. Brown A, McFarlin DE, Raine CS: Chronologic neuropathotogy of relapsing experimental allergic encephalomyelitis in the mouse. Lab Invest 1982, 46:171-185
18. Raine CS, Mokhtarian F, McFarlin DE: Adoptively transferred chronic relapsing EAE in the mouse: neuropathologic analysis. Lab Invest 1984, 51:534-546
19. Raine, CS: Biology of Disease. The analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 1984, 50:608-635
20. Mokhtarian F, McFarlin DE, Raine CS: Adoptive transfer of myelin basic protein sensitized cells produces chronic relapsing demyelinating disease in mice. Nature 1984, 309:356-358
21. Riikonen R, Ketonen L, Sipponen J: Magnetic resonance imaging, evoked responses and CSF findings in a follow-up study of children with optic neuritis. Acta Neurol Scand 1988, 77:44-49
22. Riikonen R, Donner M, Erkkila H: Optic neuritis in children and its relationship to multiple sclerosis: a clinical study of 21 children. Dev Med Child Neurol 1988, 30:349-359
23. Wolfson C, Wolfson DB: The latent period of multiple sclerosis: a critical review. Epidemiology 1993, 4:464-470
24. Deibler, GE, Martenson, RE, Kies MW: Large scale preparation of myelin basis protein from central nervous tissue of several mammalian species. Prep Biochem 1972, 2:139-165
25. Racke MK, Critchfield JM, Quigley L, Cannella B, Raine CS, McFarland HF, Lenardo MJ: Intravenous antigen therapy as therapy for autoimmune demyelinating disease. Ann Neurol 1996, 39:46-56
26. Smith ME, McFarlin DE, Dhib-Jalbut S: Differential effect of interleukin-1β on Ia expression in astrocytes and microglia. J Neuroimmunol 1993, 46:97-104
27. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119:493-503
28. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H: Differentiation between cellular apoptosis and necrosis by the combined use of in situ and tailing and nick translation techniques. Lab Invest 1994, 71:219-225
29. Bonetti B, Raine CS: Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol 1997, 42:74-84
30. Cua D, Hinton D, Stohlman S: Self-antigen induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. J Immunol 1995, 155:4052-4059
31. Voskuhl RR, Pitchekian-Halabi H, MacKenzie-Graham A, McFarland HF, Raine CS: Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann Neurol 1996, 39: 724-733
32. Mosier DE, Tigelaar RE, Cohen PL: Ontogeny of in vitro correlates of graft versus host reactions. Transplant Proc 1976, 8:371-374
33. Mosier DE, Cohen PL: Ontogeny of mouse T-lymphocyte function. Fed Proc 1975, 34:18-24
34. Raine CS, Stone SH: Animal model for multiple sclerosis: chronic experimental allergic encephalomyelitis in inbred guinea pigs. NY State J Med 1977, 77:1693-1696
35. Critchfield JM, Racke MK, Zuniga-Pflucker JC, Cannella B, Raine CS, Goverman J, Lenardo M.J: T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994, 263:1139-1143
36. Critchfield JM, Lenardo MJ: Antigen-induced programmed T cell death as a new approach to immune therapy. Clin Immunol Immunopathol 1995, 75:13-19
37. Bonetti B, Pohl J, Gao YL, Raine CS: Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J Immunol 1997, 159:5733-5741
38. Pender MP, McCombe PA, Yoong G, Nguyen KB: Apoptosis of α-beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance. J Autoimmun 1992, 5:401-410
39. Schmied M, Breitschopf H, Gold R, Zischler H, Wekerle H, Lassman H: Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 1993, 143: 446-455
40. + encephalitogenic T cells. Eur J Immunol 1994, 24:2609-2617
41. Tabi Z, McCombe PA, Pender MP: Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from EAE: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system. Int Immunol 1995, 7:967-974
42. + T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J Neurol Sci 1996, 139:1-9
43. Kohji T, Tanuma N, Aikawa Y, Kawazoe Y, Suzuki Y, Kohyama K, Matsumoto Y: Interaction between apoptotic cells and reactive brain cells in the central nervous system of rats with autoimmune encephalitis. J Neuroimmunol 1998, 82:168-174
44. Sabelko KA, Kelly KA, Nohm MH, Cross AH, Russell JH: FAS and FAS ligand enhance the pathogenesis of experimental allergic encephalomyelitis but are not essential for immune privilege in the central nervous system. J Immunol 1997, 159:3096-3099
45. Waldner H, Sobel RA, Howard E, Kuchroo VK: Fas and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol 1997, 159:3100-3103
46. Smith, ME, Raine, CS, McFarland, HF: An EAE model which allows examination of developmental changes associated with clinically relevant CNS demyelination (abstract). Trans FASEB, 1995, Atlanta, GA
47. Smith, ME, Raine, CS, McFarland, HF, Scott, DS: Resistance to clinical EAE correlates with Th2 cytokine gene expression. FASEB 9th International Congress of Immunology, July 1985, San Francisco
48. Adkins B, Ghanei A, Hamilton K: Developmental regulation of IL-4, IL-2 and IFN-γ production by murine peripheral T lymphocytes. J Immunol 1991, 151:6617-6626
49. Bogdan C, Vodovotz Y, Paik J, Xie Q, Natham C: Mechanism of suppression of nitric oxide synthase expression by IL-4 in primary mouse macrophages. J Leukoc Biol 1994, 55:227-233
50. Stenger S, Solbach W, Rollinghoff M, Bogdan C: Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-α production by macrophages is induced by the synergistic action of IFN-γ and IL-4 and accounts for the antiparastic effect mediated by IFN-γ and IL-4. Eur J Immunol 1991, 21:1669-1675
51. Foster RE, Connors BW, Waxman SG: Rat optic nerve: electrophysiological. pharmacological and anatomical studies during development. Brain Res 1982, 255:371-386
52. Waxman SG, Kocsis JD, Black JA: Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is re-expressed following axotomy. J Neurophysiol 1994, 72:466-470
53. Selmaj KW, Raine CS, Cross AH: Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991, 30:694-700
54. Selmaj KW, Raine CS: EAE: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 1995, 45:S44-S49
55. Sharief MK, Hentges R: Association between tumor necrosis factor-α and disease progression in chronic progressive multiple sclerosis N Engl J Med 1991, 325:467-472
56. Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Luer W, Helwig A, Poser S: Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 1995, 37:82-88
57. Stohlman SA, Matsushima GK, Casteel N, Frelinger JA: The defect in detayed-type hypersensitivity of young adult SJL mice is due to a lack of functional antigen-presenting cells. Eur J Immunol 1985 15:913-916
58. Massa PT, ter Meulen V: Inducibility of Ia molecules on keratinocytes reflects genetic control on astrocytes in the brain. J Neuroimmunol 1988, 19:69-75
59. Hirsh MR, Wietzerbin J, Pierres M, Goridis C: Expression of Ia antigens by cultured astrocytes treated with γ-interferon. Neurosci Lett 1983, 41:199-204
60. Sobel RA, Blanchette BW, Bhan AK, Colvin RB: The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration. J Immunol 1989, 25: 2402-2407
61. Rose LM, Peterson R, Mehra R, Alvord EC Jr.: Endothelial cell Ia increases before inflammatory cell infiltration in EAE induced in long-tailed macaques. Ann NY Acad Sci 1988, 540:315-318
62. Sasaki A, Levison SW, Ting JP-Y: Comparison and quantitation of Ia antigen expression on cultured macroglia and ameboid microglia from Lewis rat cerebral cortex: analysis and implications. J Neuroimmunol 1989, 25:63-74
63. McCarron RM, Wang L, Cowan EP, Spatz M: Class II MHC antigen expression by cultured human cerebral vascular endothelial cells. Brain Res 1991, 566:325-328
64. McCarron RM, Wang L, Stanimirovic DB, Spatz M: Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett 1993, 156:31-34
65. Fontana A, Fierz W, Wekerle H: Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 1984, 307:273-276
66. McCarron RM, Kempski O, Spatz M, McFarlin DE: Presentation of myelin basic protein by murine cerebral vascular endothelial cells. J Immunol 1985, 134:3100-3103
67. McCarron RM, Spatz M, Kempski O, Hogan RN, Muehl L, McFarlin DE: Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. J Immunol 1986, 137:3428-3435
68. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A: Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur J Immunol 1987, 17:1271-1278
69. McCarron RM, Wang L, Racke MK, McFarlin DE, Spatz M: Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J Neuroimmunol 1993, 43:23-30
70. Martin R, McFarland HF: Immunology of multiple sclerosis and experimental allergic encephalomyelitis. Multiple Sclerosis: Clinical and Pathogenetic Basis. Edited by CS Raine, HF McFarland, WW Tourtellotte. London, Chapman and Hall, 1997, pp 221-242
71. Raine, CS: The lesion in multiple sclerosis and chronic relapsing encephalomyelitis: a structural comparison. Multiple Sclerosis: Clinical and Pathogenetic Basis. Edited by CS Raine, HF McFarland, WW Tourtellotte. London, Chapman and Hall, 1997, pp 243-286